Entera Bio Ltd.
ENTX
$1.99
$0.010.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -48.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -48.78% | |||
| Cost of Revenue | -- | -48.78% | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -20.28% | 26.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.42% | 7.69% | |||
| Operating Income | -4.10% | -9.67% | |||
| Income Before Tax | -3.47% | -9.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.47% | -8.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.47% | -8.86% | |||
| EBIT | -4.10% | -9.67% | |||
| EBITDA | -4.15% | -9.85% | |||
| EPS Basic | 4.22% | 1.82% | |||
| Normalized Basic EPS | 4.32% | 1.33% | |||
| EPS Diluted | 4.22% | 1.82% | |||
| Normalized Diluted EPS | 4.32% | 1.33% | |||
| Average Basic Shares Outstanding | 7.97% | 10.91% | |||
| Average Diluted Shares Outstanding | 7.97% | 10.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||